Related Experiment Video
Updated: Sep 4, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Post-transplant Diabetes Mellitus: What Physicians Need to Know
1Senior Consultant Nephrologist and Kidney Transplant Physician, Department of Nephrology and Kidney Transplantation, Virinchi Hospitals, Hyderabad, Telangana, India; Corresponding Author.
Post-transplant diabetes mellitus (PTDM) is a frequent complication in organ transplant recipients, impacting survival. Management requires understanding its complex causes and employing therapeutic strategies.
Area of Science:
- Nephrology
- Endocrinology
- Immunology
Background:
- Post-transplant diabetes mellitus (PTDM) is a significant complication following solid organ transplantation (SOT).
- PTDM adversely affects patient and graft survival, increasing morbidity.
- Its incidence peaks in the early post-transplant period and again years later.
Purpose of the Study:
- To provide a concise review of PTDM in SOT recipients.
- To offer a general physician's perspective on PTDM management.
- To highlight the importance of glycemic control in SOT patients.
Main Methods:
- This article presents a point-of-view review.
- It synthesizes current understanding of PTDM pathogenesis and treatment.
- Focuses on aspects relevant to general physicians.
Main Results:
- PTDM pathogenesis involves complex interactions, including beta-cell dysfunction and insulin resistance.
- Both non-pharmacologic and pharmacologic interventions are crucial for glycemic control.
- Early and long-term monitoring is essential.
Conclusions:
- PTDM is a prevalent and serious complication in SOT.
- Effective management strategies are vital for improving outcomes.
- Further research into PTDM pathogenesis and treatment is warranted.
Related Concept Videos
Kidney Transplant III: Nursing Management
Diabetes Mellitus: Type 2 and Gestational
Kidney Transplant I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications

